Dr. Mark M. Zalupski

Claim this profile

University of Michigan Comprehensive Cancer Center

Studies Cancer
Studies Small Intestinal Cancer
5 reported clinical trials
16 drugs studied

Area of expertise

1

Cancer

Mark M. Zalupski has run 3 trials for Cancer. Some of their research focus areas include:

PD-L1 positive
ERK 1/2 positive
MEK 1/2 positive
2

Small Intestinal Cancer

Mark M. Zalupski has run 2 trials for Small Intestinal Cancer. Some of their research focus areas include:

Stage IV
Stage III
PD-L1 positive

Affiliated Hospitals

Image of trial facility.

University Of Michigan Comprehensive Cancer Center

Image of trial facility.

University Of Michigan - Brighton Center For Specialty Care

Clinical Trials Mark M. Zalupski is currently running

More about Mark M. Zalupski

Clinical Trial Related

9 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Mark M. Zalupski has experience with

  • Hydroxychloroquine
  • Ulixertinib
  • Fluorouracil
  • Irinotecan
  • Irinotecan Hydrochloride
  • Leucovorin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Mark M. Zalupski specialize in?

Is Mark M. Zalupski currently recruiting for clinical trials?

Are there any treatments that Mark M. Zalupski has studied deeply?

What is the best way to schedule an appointment with Mark M. Zalupski?

What is the office address of Mark M. Zalupski?

Is there any support for travel costs?